Phacilitate Leaders World

Conference speakers

Loading
Giacomo Lunerti

Giacomo Lunerti

RPS Aerospace , Chief Technology Officer

Born in 1988 he is  the CTO and Co-Founder of RPS AEROSPACE S.r.l., an Italian Company that produces and develops Unmanned Multi Role Rotorcrafts for Civilian missions. He graduated in Mechanical engineering at the Polytechnic of Milan and developed projects related to civilian aviation.

He's now applicant in two patented technology about flight safety and is responsible at RPS AEROSPACE for DISCOVERY VTOL platform development, an unmanned "light class" rotorcraft that will be certified for the BVLOS category.

More about Giacomo...

  • At 17 developed a high efficiency car prototype recognized by Royal Dutch Shell as the most advanced design car prototype, able to run up to 200km with one liter of petrol.
  • At 21 founded Etech, a company based in Italy that develops systems to simulate hard rescue conditions. Systems are used by the Red Cross to train rescuer
  • At 22 developed a patented cabin size luggage (licensed to a big luggage company) able to turn into an electric scooter without loosing the luggage space
  • At 23 founded with Nausicaa Vezzoli RPS AEROSPACE with the vision to create little aircraft able to reach the safety level of a jet liner (i.e. Airbus 320) and fly everywhere without limitations. Added values can be made by Artificial Vision Intelligence that creates “aircraft who can think”.


 

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK